Literature DB >> 11073536

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).

A R Lafferty1, D J Torpy, M Stowasser, S E Taymans, J P Lin, P Huggard, R D Gordon, C A Stratakis.   

Abstract

Familial hyperaldosteronism type II (FH-II) is caused by adrenocortical hyperplasia or aldosteronoma or both and is frequently transmitted in an autosomal dominant fashion. Unlike FH type I (FH-I), which results from fusion of the CYP11B1 and CYP11B2 genes, hyperaldosteronism in FH-II is not glucocorticoid remediable. A large family with FH-II was used for a genome wide search and its members were evaluated by measuring the aldosterone:renin ratio. In those with an increased ratio, FH-II was confirmed by fludrocortisone suppression testing. After excluding most of the genome, genetic linkage was identified with a maximum two point lod score of 3.26 at theta=0, between FH-II in this family and the polymorphic markers D7S511, D7S517, and GATA24F03 on chromosome 7, a region that corresponds to cytogenetic band 7p22. This is the first identified locus for FH-II; its molecular elucidation may provide further insight into the aetiology of primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073536      PMCID: PMC1734468          DOI: 10.1136/jmg.37.11.831

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  31 in total

Review 1.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  A radiation hybrid map of the human genome.

Authors:  G Gyapay; K Schmitt; C Fizames; H Jones; N Vega-Czarny; D Spillett; D Muselet; J F Prud'homme; C Dib; C Auffray; J Morissette; J Weissenbach; P N Goodfellow
Journal:  Hum Mol Genet       Date:  1996-03       Impact factor: 6.150

3.  A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue.

Authors:  A M Kvingedal; E B Smeland
Journal:  FEBS Lett       Date:  1997-04-21       Impact factor: 4.124

4.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

5.  Genetic variation in P450c11AS in Chilean patients with low renin hypertension.

Authors:  C E Fardella; H Rodriguez; J Montero; G Zhang; P Vignolo; A Rojas; L Villarroel; W L Miller
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

6.  Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.

Authors:  J H Hansson; C Nelson-Williams; H Suzuki; L Schild; R Shimkets; Y Lu; C Canessa; T Iwasaki; B Rossier; R P Lifton
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

7.  High incidence of primary aldosteronism in 199 patients referred with hypertension.

Authors:  R D Gordon; M Stowasser; T J Tunny; S A Klemm; J C Rutherford
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-04       Impact factor: 2.557

Review 8.  Disorders of steroid 11 beta-hydroxylase isozymes.

Authors:  P C White; K M Curnow; L Pascoe
Journal:  Endocr Rev       Date:  1994-08       Impact factor: 19.871

9.  Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.

Authors:  C A Stratakis; J A Carney; J P Lin; D A Papanicolaou; M Karl; D L Kastner; E Pras; G P Chrousos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension?

Authors:  C E Fardella; H Rodriguez; D W Hum; S H Mellon; W L Miller
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

View more
  37 in total

Review 1.  Primary aldosteronism: rare bird or common cause of secondary hypertension?

Authors:  M Stowasser
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

3.  Non-glucocorticoid-remediable aldosteronism in an infant with low-renin hypertension.

Authors:  Maricarmen Malagon-Rogers
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

4.  Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity.

Authors:  Elvira Haas; Indranil Bhattacharya; Eugen Brailoiu; Marlen Damjanović; G Cristina Brailoiu; Xin Gao; Laurence Mueller-Guerre; Nicole A Marjon; André Gut; Roberta Minotti; Matthias R Meyer; Kerstin Amann; Emerita Ammann; Ana Perez-Dominguez; Michele Genoni; Deborah J Clegg; Nae J Dun; Thomas C Resta; Eric R Prossnitz; Matthias Barton
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

Review 5.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

6.  Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1.

Authors:  Harshal Waghulde; Xi Cheng; Sarah Galla; Blair Mell; Jingwei Cai; Shondra M Pruett-Miller; Guillermo Vazquez; Andrew Patterson; Matam Vijay Kumar; Bina Joe
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 7.  Differential diagnosis of primary aldosteronism subtypes.

Authors:  Paolo Mulatero; Chiara Bertello; Andrea Verhovez; Denis Rossato; Giuseppe Giraudo; Giulio Mengozzi; Giorgio Limerutti; Eleonora Avenatti; Davide Tizzani; Franco Veglio
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 8.  Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-13       Impact factor: 3.072

9.  Adrenocortical causes of hypertension.

Authors:  Andreas Moraitis; Constantine Stratakis
Journal:  Int J Hypertens       Date:  2011-03-08       Impact factor: 2.420

Review 10.  Heritable forms of hypertension.

Authors:  V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.